Pixyl
French tech company | Builders Republic
About
AI-powered MRI analysis platform that helps radiologists and neurologists detect and quantify biomarkers of neuroinflammatory and neurodegenerative disorders — from lesion segmentation to brain volume measurement, integrated directly into existing radiology workflows. FDA-cleared (Class II) and CE-marked (Class IIa). Now part of Gleamer.
Key facts
- Status
- Rachetée
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2015
- City
- LA TRONCHE
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 2.2 M€ raised since 2020
Funding rounds
- Seed · 2021
Investors
Notes
Rachetée par Gleamer. Opération annoncée en mars 2025 (Tech.eu — https://tech.eu/2025/03/11/gleamer-acquires-pixyl-and-caerus-medical-a-leap-forward-in-ai-driven-radiology/).